Today in News History
On July 12, several notable moments in the history of News stand out. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1909, Fritz Leonhardt, German engineer, designed Fernsehturm Stuttgart (died 1999) was born. In 1910, Charles Rolls, English engineer and businessman, co-founded Rolls-Royce Limited (born 1877) passed away. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. In 2006, The 2006 Lebanon War begins. In 2012, George C. Stoney, American director and producer (born 1916) passed away. In 2013, Amar Bose, American businessman, founded the Bose Corporation (born 1929) passed away. In 2015, Cheng Siwei, Chinese engineer, economist, and politician (born 1935) passed away. In 2024, Evan Wright, American writer (born 1964) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
Narrative Analysis: Card Stacking
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.
Narrative Intelligence Brief
This article was published by CNBC, a source frequently categorized with a lean left bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. In this specific piece, our systems detected the potential use of the "Card Stacking" technique. This narrative approach is often used to shape reader perception by highlighting specific emotional or rhetorical angles. By understanding the editorial perspective of CNBC, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from CNBC
July 11, 2026
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
July 10, 2026
Inside Wealth: Private chef salaries reach $300,000 as the rich seek their own Michelin stars
July 10, 2026
Private chef salaries reach $300,000 as the rich seek their own Michelin stars
July 10, 2026
Delta expects higher airfare to last, bringing 2026 profit goal in reach, CEO says
July 9, 2026
Florida's Palm Beach airport renamed for Trump
Reliability Insights
P
Technique: Card Stacking
System analysis detected use of specific narrative techniques in this piece.Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"cup semifinals"
Julian Alvarez's strike sends defending champion Argentina back to World Cup semifinals
World Cup 2026 Saturday takeaways: Jude Bellingham shines; Argentina takes advantage of Swiss flop
2026 World Cup Semifinal Odds: France, Argentina Favored In Final Four Tilts
How other outlets are covering this story
Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
6 sources
Left 17%
Center 33%
Right 33%
Seeking Alpha
· Jun 23, 2026
Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities
Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities
Voice of Nigeria
· Jun 29, 2026
FDA Reviews Sandoz Generic Obesity Drug Applications
The U.S. Food and Drug Administration (FDA) has accepted for review two generic versions of tirzepatide developed by Swiss pharmaceutical company Sandoz, a move that could pave the way for increased competition in the rapidly expanding obesity and diabetes treatment market. If approved, the medicines would become direct competitors to Eli Lilly’s blockbuster tirzepatide brands, [] The post FDA Reviews Sandoz Generic Obesity Drug Applications appeared first on Voice of Nigeria.
Vogue
· Jun 26, 2026
Is Bodycare Luxury Beauty’s Next Frontier?
The bodycare category is booming as more brands enter the space and players such as L’Oréal’s Bold and Advent International invest early.
TechCrunch
· Jul 1, 2026
Bending Spoons defies SaaS slump, surges 40% on first day of trading
The company has grown rapidly by acquiring and revamping last-generation tech brands like AOL, Eventbrite, Evernote, Meetup, and Vimeo.
The Eastern Herald
· Jul 3, 2026
Eli Lilly’s Unapproved Weight-Loss Drug Is Now Sold at Brooklyn Corner Stores for $95
A CBS News reporter purchased Eli Lilly's experimental weight-loss drug retatrutide at a Brooklyn convenience store for 95 with no prescription as toxicity reports rise and the FDA warns such products are of unknown quality and potentially harmful. The drug is currently in clinical trials and has never received regulatory approval.
Economic Times
· Jun 23, 2026
Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal Manchanda
India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and consumer healthcare. While US FDA approvals for complex generics remain a challenge, innovation and contract manufacturing offer significant future profit pools. Experts anticipate biosimilars could generate substantial revenue, and despite a slow start, GLP-1 drugs show long-term promise. Sun Pharma is highlighted as a preferred domestic investment.
Topics:
Related coverage for "Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities": Seeking Alpha — Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities. Voice of Nigeria — FDA Reviews Sandoz Generic Obesity Drug Applications. Vogue — Is Bodycare Luxury Beauty’s Next Frontier?. TechCrunch — Bending Spoons defies SaaS slump, surges 40% on first day of trading. The Eastern Herald — Eli Lilly’s Unapproved Weight-Loss Drug Is Now Sold at Brooklyn Corner Stores for $95. Economic Times — Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal Manchanda